These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7294907)

  • 1. [Treatment of toxoplasmosis. present knowledge and problems (author's transl)].
    Russo M; Galanti B; Nardiello S
    Ann Sclavo; 1980; 22(6):877-88. PubMed ID: 7294907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five drug regimens for treatment of acute toxoplasmosis in squirrel monkeys.
    Harper JS; London WT; Sever JL
    Am J Trop Med Hyg; 1985 Jan; 34(1):50-7. PubMed ID: 3970309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of toxoplasmosis].
    Terragna A; Canessa A
    G Ital Chemioter; 1984; 31(1-2):7-15. PubMed ID: 6381209
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental toxoplasmosis in mice. Comparative activity of clindamycin, midecamycin, josamycin, spiramycin, pyrimethamine-sulfadoxine, and trimethoprim-sulfamethoxazole].
    Garin JP; Paillard B
    Ann Pediatr (Paris); 1984 Nov; 31(10):841-5. PubMed ID: 6517460
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole), pyrimethamine-sulphadiazine and spiramycin during avirulent infection with Toxoplasma gondii (Beverley strain) in mice.
    Nguyen BT; Stadtsbaeder S
    Br J Pharmacol; 1983 Aug; 79(4):923-8. PubMed ID: 6606459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative Chemotherapeutical studies on the effect of Bactrim and other combined preparations on the proliferative and cystforming phase of Toxoplasma gondii in NMRI mice. A contribution to experimental chemotherapy of toxoplasmosis (author's transl)].
    Werner H; Egger I
    Zentralbl Bakteriol Orig A; 1975; 231(1-3):349-64. PubMed ID: 1154912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparison of Ultrax, Diazil, Bactrim and Spiramycin in experimental toxoplasmosis in mice (author's transl)].
    Coradello H; Kretschmer S
    Wien Klin Wochenschr; 1978 Jan; 90(1):25-9. PubMed ID: 625985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy in experimental toxoplasmosis: comparison of the efficacy of trimethoprim-sulfur and pyrimethamine-sulfur combinations.
    Seah SK
    J Trop Med Hyg; 1975 Jul; 78(7):150-3. PubMed ID: 1177347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
    Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
    Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review.
    Iaccheri B; Fiore T; Papadaki T; Androudi S; Janjua S; Bhaila I; Stephen Foster C
    Clin Ther; 2008 Nov; 30(11):2069-74. PubMed ID: 19108794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-toxoplasmosis drugs.
    Derouin F
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1368-74. PubMed ID: 11890349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contribution to the diagnostics and treatment of toxoplasmosis (author's transl)].
    Skála V
    Cesk Gynekol; 1974 Jul; 39(6):450-1. PubMed ID: 4848381
    [No Abstract]   [Full Text] [Related]  

  • 13. Treating toxoplasmosis.
    Nye FJ
    J Antimicrob Chemother; 1979 May; 5(3):244-6. PubMed ID: 479059
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic approaches for AIDS-related toxoplasmosis.
    Behbahani R; Moshfeghi M; Baxter JD
    Ann Pharmacother; 1995; 29(7-8):760-8. PubMed ID: 8520094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Our approach to prevention and treatment of toxoplasmosis (author's transl)].
    Raffaj J; Schmidt K
    Cesk Gynekol; 1974 Jul; 39(6):449-50. PubMed ID: 4849325
    [No Abstract]   [Full Text] [Related]  

  • 16. [Toxoplasmosis: modern diagnostic and therapeutic management (Part II)].
    Shimoni Z; Flatau E; Raz R
    Harefuah; 1988 Dec; 115(12):390-3. PubMed ID: 3071510
    [No Abstract]   [Full Text] [Related]  

  • 17. A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans.
    Wei HX; Wei SS; Lindsay DS; Peng HJ
    PLoS One; 2015; 10(9):e0138204. PubMed ID: 26394212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current treatment of ocular toxoplasmosis in immunocompetent patients: a network meta-analysis.
    Zhang Y; Lin X; Lu F
    Acta Trop; 2018 Sep; 185():52-62. PubMed ID: 29704469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two medications in central nervous system toxoplasmosis in patients with AIDS.
    Antinori A; Ammassari A; Maiuro G; Camilli G; Damiano F; Federico G; Pizzigallo E; Tamburrini E
    Ital J Neurol Sci; 1992 Sep; 13(6):475-9. PubMed ID: 1428784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of clindamycin in the treatment of acute toxoplasmosis of the central nervous system.
    Ruf B; Pohle HD
    Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):183-6. PubMed ID: 2060525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.